[ad_1]
In countries such as the United States, Canada and the Netherlands, hemp enjoys increasing popularity as a drug – and also as an badgesic. An Australian study is now dismissive: Cannabis is not suitable as an alternative to opiates.
"There was no suggestion that cannabis reduces the intensity of pain or has an opioid-saving effect," writes Gabrielle Campbell of the University. from New South Wales. Authors in the journal "The Lancet Public Health."
During the investigation, cannabis use was observed in (non-cancerous) patients with pain receiving opioids as badgesics prescribed by their physician for more than four years. in the United States
The frequent prescription of opioids in patients with chronic pain has led to an addiction problem growing alarmingly in the United States since the 1990s. In 2016, 42,000 people died Opioids – more than ever before. This is one of the reasons why researchers are looking for ways to reduce the amount of opiates.
According to the Australian study, cannabis does not really fit that. "We have found no evidence of a temporal relationship between cannabis use and the severity of pain symptoms," the authors write. Although some subjects reduced or discontinued their painkillers during the study period, the researchers found no connection to cannabis use.
Researchers report positive information about cannabis in the "British Journal of Pharmacology". He says: The ingredients of the plant could inhibit the cell division of tumors and stimulate the immune system in the fight against cancerous tissues
Austria: Report on Planning
The Health Committee of the National Council has Minister Beate Hartinger-Klein (FPÖ) It has recently been unanimously requested to produce a report on the therapeutic use of cannabis in medicine by the end of 2018.
In the spring, the German Fund will Health insurance technicians published an expert report on this topic with his support. Conclusion: "Do not expect miracles from cannabis." In pain medicine and paralysis, the quality of scientific evidence of efficacy is "at most moderate"
science.ORF.at/APA
